FOLH1 and neoplasm: Stringent selection based on dual PSMA and FDG PET imaging might represent a more optimal approach to exclude patients who are less likely to respond to 177Lu-PSMA-617, and we mighty have observed greater anti-tumour activity had such an approach been employed.